Spirulina and Iron Homeostasis: Hepcidin-Ferroportin and Anemia of Inflammation

Hepcidin: The Master Iron Regulator

Hepcidin (HAMP gene) is a 25-amino-acid hepatic peptide hormone that controls systemic iron availability. It binds ferroportin (SLC40A1) — the only known cellular iron exporter — on enterocyte basolateral membranes, macrophage surfaces, and hepatocytes, triggering ferroportin internalization, ubiquitination, and lysosomal degradation. With ferroportin destroyed, iron is trapped intracellularly (ferritin storage) and unavailable for erythropoiesis or peripheral utilization.

BMP/SMAD: The Iron-Sensing Pathway

Under iron-replete conditions, hepatic sinusoidal endothelial cells produce BMP6 (bone morphogenetic protein 6), which binds BMP receptors and HJV (hemojuvelin) on hepatocytes, activating SMAD1/5/8 phosphorylation and SMAD4-mediated HAMP transcription. This is the canonical, iron-responsive arm: high iron → BMP6 → hepcidin → ferroportin downregulation → reduced absorption and recycling.

IL-6/STAT3: The Inflammatory Override

During chronic inflammation, IL-6 binds IL-6R/gp130 on hepatocytes, activating JAK1/2 and phosphorylating STAT3 at Tyr705. Phospho-STAT3 dimerizes, translocates to the nucleus, and binds the STAT3 response element in the HAMP promoter — driving hepcidin transcription independent of iron status. This produces functional iron deficiency: serum iron drops, ferritin (acute-phase reactant) rises, transferrin saturation falls below 16%, and erythropoiesis is iron-restricted despite adequate stores. This is anemia of inflammation (AI), the second most common anemia globally.

Spirulina Suppresses IL-6 and STAT3

Phycocyanin's NF-κB suppression reduces IL-6 transcription by 30–50% in clinical studies. Direct STAT3 inhibition occurs via SOCS3 (suppressor of cytokine signaling 3) upregulation, which feedback-inhibits JAK-STAT signaling. Phycocyanin increases SOCS3 expression by 25–40%, reducing phospho-STAT3 nuclear accumulation and HAMP transcription. Net effect: 20–35% reduction in serum hepcidin in chronic inflammation models.

Ferroportin Restoration and Iron Mobilization

With hepcidin suppressed, ferroportin recycling is restored on enterocyte basolateral membranes (enabling dietary iron absorption), splenic macrophages (recycling iron from senescent erythrocytes — the largest daily iron flux at ~25 mg/day), and hepatocytes (releasing storage iron). Clinical evidence: 30–45% increase in transferrin saturation, 20–35% increase in serum iron, and 15–25% increase in hemoglobin in iron-restricted erythropoiesis after 8–12 weeks.

Spirulina's Bioavailable Iron Content

Beyond hepcidin modulation, spirulina contains 28–42 mg iron per 100 g dry weight, primarily as ferritin-bound iron (similar to legume iron, which uses ferritin endocytic uptake bypassing DMT1). Bioavailability is enhanced by spirulina's vitamin C content and phycocyanin chelation that protects iron from oxidation in the GI tract. Combined with hepcidin reduction, this creates a unique "intake + utilization" advantage over conventional iron supplementation.

Conclusion

Spirulina addresses iron deficiency through two parallel mechanisms: (1) suppression of IL-6-STAT3-driven hepcidin transcription, restoring ferroportin and enabling iron mobilization from stores and absorption; (2) bioavailable iron provision via ferritin-bound iron. Clinical correlates: 20–35% hepcidin reduction, 30–45% transferrin saturation increase, 15–25% hemoglobin elevation in inflammation-associated anemia. The combination is uniquely suited for the substantial population — chronic kidney disease, IBD, rheumatoid arthritis, obesity, heart failure — where iron deficiency is functional rather than absolute and oral iron salts are poorly absorbed due to hepcidin lock.